ACOG Menu

Clinical Guidance

  • Practice Advisory PA
2020
FDA Releases New Guidance and Draft Product Labeling for Laparoscopic Power Morcellators
March 2020
Options for Peripartum Anticoagulation in Areas Affected by Shortage of Unfractionated Heparin
March 2020
Novel Coronavirus 2019 (COVID-19)
March 2020
2019
FDA Warning About Fluoroquinolones and Risk of Aortic Ruptures or Tears
November 2019
Clinical Guidance for Integration of the Findings of the PROLONG Study: Progestin’s Role in Optimizing Neonatal Gestation
October 2019
Lung Injury Associated with E-cigarettes (“Vaping”)
October 2019
FDA Approval of 9-valent HPV Vaccine for Use in Women and Men Age 27-45
June 2019
Management of Pregnant and Reproductive Aged Women during a Measles Outbreak
April 2019
Cell-free DNA to Screen for Single-Gene Disorders
February 2019
2018
Cervical Cancer Screening (Update)
August 2018
Clinical Guidance for Integration of the Findings of The ARRIVE Trial: Labor Induction Versus Expectant Management in Low-Risk Nulliparous Women
August 2018
Response to FDA’s Authorization of BRCA1 and BRCA2 Gene Mutation Direct-to-Consumer Testing
May 2018
Hormonal Contraception and Risk of Breast Cancer
January 2018
Hepatitis B Prevention
January 2018
2017
FDA Removal of Boxed Warning on Varenicline and Bupropion
November 2017
Update on Seafood Consumption During Pregnancy
January 2017
2016
FDA Warnings Regarding Use of General Anesthetics and Sedation Drugs in Young Children and Pregnant Women
December 2016
FDA Boxed Warning on Immediate-Release Opioid Medications and All Prescription Opioids
March 2016